Updated: 2012-05-21 23:38:12
Sighting false positive test results, over diagnosis, and over treatment, the United States Preventive Services Task Force today issued a final recommendation on prostate specific antigen testing for prostate cancer, giving it a “D” rating. The rating means that the … Continue reading →
Updated: 2012-05-21 18:01:39
Rheumatoid arthritis patients have a higher risk of early death than the average person does, and cardiovascular disease is one reason. A new Mayo Clinic study shows that heart disease risk assessment tools commonly used by physicians often underestimate the danger … Continue reading →
Updated: 2012-05-21 18:00:56
Mayo Clinic is joining with the Lupus Foundation of America for a Facebook chat on lupus this week as part of Lupus Awareness Month. Mayo Clinic rheumatologist Vai Chowdhary, M.D., will take questions online at https://www.facebook.com/LupusFoundationofAmerica on Wednesday, May 23, from 2 to 3 p.m. ET. The … Continue reading →
Updated: 2012-05-17 15:02:54
Exposure to the JC virus, previous immunosuppressant therapy, and time on natalizumab (Tysbari) appear to predict risk of developing a life-threatening side effect in multiple sclerosis patients, researchers confirmed.
Updated: 2012-05-15 17:23:03
Mayo Clinic has created a comprehensive mobile health application; combining a custom mobile experience with unparalleled expertise and access. Empowering patients with information at their fingertips, this app sets a new standard for health care apps. The Mayo Clinic patient … Continue reading →
Updated: 2012-05-14 22:17:54
May is Stroke Awareness Month, held to draw attention to the fact that in the United States, stroke is the fourth leading cause of death, killing over 133,000 people each year, and a leading cause of serious, long-term adult disability. … Continue reading →
Updated: 2012-05-14 05:54:19
WASHINGTON -- Reacting to a death associated with the multiple sclerosis drug fingolimod (Gilenya), the FDA said patients with certain cardiac risk factors should not take the oral agent.
Updated: 2012-05-14 05:00:00
Smoking marijuana cuts spasticity and pain that's resistant to conventional therapy in multiple sclerosis, although with some cognitive effects, a small clinical trial affirmed.
Updated: 2012-05-10 16:35:47
WASHINGTON -- The FDA has issued an alert about risks, including death, associated with treatment of chronic cerebrospinal venous insufficiency (CCSVI), which some believe causes or exacerbates multiple sclerosis.
Updated: 2012-05-09 19:06:08
Patients across the nation are faced with a dilemma when it comes to mental health care: There aren’t enough psychiatrists to treat their needs. Exacerbating the problem is that when a patient is having mental health problems, they will most … Continue reading →
Updated: 2012-05-06 19:07:39
Dr. Mark Frye, chair of the department of psychology and psychiatry at Mayo Clinic, participated in a discussion on state-of-the-art treatments for bipolar disorder Sunday at the 2012 American Psychiatric Association meeting. The panel featured some of the top names … Continue reading →
Updated: 2012-05-05 23:00:41
On Saturday May 5 at the American Psychiatric Association meeting, Mayo Clinic Health System psychiatrist Mohit Chauhan, M.D., gave an update on the Mayo Clinic Bipolar Disorder Biobank. Biobanks are a repository used to store human biological samples for use … Continue reading →
Updated: 2012-05-04 22:39:48
It’s a stunning disparity: Sixty percent of children with cancer are in clinical trials, compared with only about 6 percent of adult cancer patients. That low level of engagement holds true for adults with other conditions, and participation rates fall even … Continue reading →
Updated: 2012-04-29 18:53:25
NEW ORLEANS -- Accidental fetal exposure to natalizumab did not appear associated with adverse effects in pregnant multiple sclerosis patients, according to small studies presented here.
Updated: 2012-04-27 23:06:33
NEW ORLEANS -- Among patients with relapsing-remitting multiple sclerosis, little clinical benefit was seen for combining glatiramer acetate with interferon beta-1a versus either drug alone in a large randomized trial.
Updated: 2012-04-27 14:03:13
NEW ORLEANS -- The clinical course of multiple sclerosis does not appear to be affected by advent of menopause, researchers said here.
Updated: 2012-04-26 21:32:34
NEW ORLEANS -- Occlusions in cerebrospinal veins imaged with ultrasound and magnetic resonance venography do not appear to be related to multiple sclerosis, researchers said here.
Updated: 2012-04-26 14:58:17
NEW ORLEANS -- Being a woman and being young at diagnosis of multiple sclerosis were key hallmarks that allowed for "benign" disease over two decades or more, researchers said here.
Updated: 2012-04-25 23:01:49
NEW ORLEANS -- Dimethyl fumarate (BG-12) showed good efficacy and safety in the pivotal, phase III CONFIRM trial, in line with results from an earlier phase III study.
Updated: 2012-04-25 21:29:12
NEW ORLEANS -- Alemtuzumab (Lemtrada, Campath) dramatically reduced multiple sclerosis relapses in patients with long-term disease -- with just once-a-year treatment, researchers reported here.
Updated: 2012-04-25 16:44:36
NEW ORLEANS -- Multiple sclerosis patients treated with natalizumab were more likely to discontinue therapy after learning of a positive JCV antibody result, only to see a higher risk for relapse, according to a single-center study.
